Governor Gray Davis joins Genesis Biopharma
This article was originally published in Scrip
Executive Summary
Former California governor Gray Davis has joined Genesis Biopharma, a biotech company developing targeted cancer therapies, as chairman of its corporate advisory board. During Mr Davis' tenure as governor, California became a leader in stem cell research and provided high levels of funding for cancer and HIV research and treatment.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.